These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5427901)

  • 1. The relationship between delayed hypersensitivity responses and blood steroid and androgen levels in cancer patients.
    Mackay WD; Bulbrook RD; Want D
    Br J Surg; 1970 May; 57(5):386. PubMed ID: 5427901
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between plasma-cortisol, plasma-androgen-sulphates, and immune response in women with breast cancer.
    Mackay WD; Bulbrook RD; Wang DY; Edwards MH
    Lancet; 1971 Nov; 2(7732):1001-2. PubMed ID: 4108064
    [No Abstract]   [Full Text] [Related]  

  • 3. PHA and PPD skin responses in cancer patients.
    Sinha R; Abassi KA; Gupta SC; Naithani YP
    Indian J Cancer; 1983; 20(5):227-31. PubMed ID: 6680390
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the immunological reactivity and hormonal profile in patients with breast cancer].
    Baisheva SA; Bogdanova AG
    Vopr Onkol; 1984; 30(12):19-23. PubMed ID: 6516268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sequential changes in hormone levels in postmenopausal breast cancer patients under long-term treatment with an aromatase inhibitor. Kanagawa AI Study Group].
    Fukuda M; Watanabe H; Suda T; Shimizu S
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2201-8. PubMed ID: 10635305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients].
    Bershteĭn LM; Buslaeva VP; Kondrat'ev VB; Ostroumova MN; Semiglazov VF
    Vopr Onkol; 1980; 26(12):28-31. PubMed ID: 7467216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
    Harris KA; Weinberg V; Bok RA; Kakefuda M; Small EJ
    J Urol; 2002 Aug; 168(2):542-5. PubMed ID: 12131305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hypersensitivity in breast cancer.
    Roberts MM; Williams WJ
    Br J Surg; 1968 Nov; 55(11):869. PubMed ID: 5687020
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum cortisol fractions in breast cancer].
    Miura S; Ariyoshi Y; Yoshida M; Murai H; Yamamoto M; Niinomi M; Matsui N
    Gan No Rinsho; 1983 Oct; 29(12):1417-23. PubMed ID: 6645060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in delayed hypersensitivity between breast and cervical carcinomas.
    Munzarová M; Kovarík J; Ptácková B; Hlávková J; Kolcová V; Nebeský T
    Neoplasma; 1984; 31(1):95-8. PubMed ID: 6700799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial immunologic evaluations in breast and thyroid cancer].
    Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
    Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delayed hypersensitivity reactions in cancer patients: influence of the clinical stage and chemo- and radiotherapy on the immune status].
    Bouckenaere-Wojcik D; Delzenne G; Deckers C
    Bull Cancer; 1982; 69(5):468-75. PubMed ID: 7165809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
    Fan XJ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
    [No Abstract]   [Full Text] [Related]  

  • 20. Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates.
    Troisi R; Lagiou P; Trichopoulos D; Xu B; Chie L; Stanczyk FZ; Potischman N; Adami HO; Hoover RN; Hsieh CC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):224-31. PubMed ID: 18199728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.